Cargando…
Cost-effectiveness of drug therapies for Alzheimer’s disease: A brief review
Alzheimer’s disease (AD) is an important and rapidly expanding public health problem. Its large economic burden is a result of its disabling nature, chronicity, and high prevalence in older segments of the population. Current treatments of AD have been criticized for providing insufficient benefit t...
Autor principal: | Geldmacher, David S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526383/ https://www.ncbi.nlm.nih.gov/pubmed/18830441 |
Ejemplares similares
-
A Brief Review on the Potential of Psychedelics for Treating Alzheimer’s Disease and Related Depression
por: Pilozzi, Alexander, et al.
Publicado: (2023) -
Non-drug Therapies for Alzheimer’s Disease: A Review
por: Li, Xianqian, et al.
Publicado: (2022) -
Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review
por: Park, Jong-Chan, et al.
Publicado: (2020) -
Down Syndrome, Obesity, Alzheimer’s Disease, and Cancer: A Brief Review and Hypothesis
por: Nixon, Daniel W.
Publicado: (2018) -
Disparities Research at the Deep South Alzheimer’s Disease Center of the University of Alabama at Birmingham
por: Pisu, Maria, et al.
Publicado: (2021)